Award

Delivery Order #SPE2DR26F9TM1

Short-Term Delivery Order for Chemotherapy Drug by AmerisourceBergen

Buyer

Defense Logistics Agency

Award Amount

$667.60

Ceiling

$667.60

Awarded

March 02, 2026

Period of Performance

Mar 02, 2026 – Mar 03, 2026

Identifier

SPE2DR26F9TM1

NAICS

424210

This recent contract award is a delivery order under an existing indefinite delivery vehicle agreement with AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company. The delivery order specifically procures vials of Cisplatin, a chemotherapy medication critical for cancer treatment. The award exemplifies the agency's ongoing efforts to maintain reliable access to essential pharmaceuticals required for patient care. The scope involves timely delivery of specified medication to a designated location, ensuring continuity of supply for healthcare providers. This contract was awarded competitively as part of the broader established vehicle, leveraging AmerisourceBergen's extensive distribution capabilities. The performance period is brief, spanning a couple of days, reflecting the nature of timely pharmaceutical deliveries. It supports the agency's long-term pharmaceutical supply chain under the parent contract, solidifying critical healthcare resource availability.

Description

4571003373!CISPLATIN 100 MG/100 ML VIAL 100ML

View original record